With shares of Caribou Biosciences (NASDAQ: CRBU) up by 51% in the past 30 days, there's more than one reason why you might want to consider a purchase for yourself. Between its recent release of some ...
Caribou's cell therapy programs are among the most advanced that exist. So far, they also appear to be relatively safe and quite effective. The company has more than enough money to reach its next ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback